Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/60323, first published .
A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET–Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective Study

A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET–Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective Study

A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET–Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective Study

Ali Janbain   1 , PhD ;   Andrea Farolfi   2 , MD ;   Armelle Guenegou-Arnoux   1 , MSc, PHD ;   Louis Romengas   1 , MSc ;   Sophia Scharl   3 , MD ;   Stefano Fanti   2 , MD ;   Francesca Serani   2 , MD ;   Jan C Peeken   4 , MD ;   Sandrine Katsahian   1 , PHD ;   Iosif Strouthos   5 , MD ;   Konstantinos Ferentinos   5 , MD ;   Stefan A Koerber   6 , MD ;   Marco E Vogel   4 , MD ;   Stephanie E Combs   4 , MD ;   Alexis Vrachimis   5 , MD ;   Alessio Giuseppe Morganti   7 , MD ;   Simon KB Spohn   8 , MD ;   Anca-Ligia Grosu   8 , MD ;   Francesco Ceci   9 , MD ;   Christoph Henkenberens   10 , MD ;   Stephanie GC Kroeze   11 , MD ;   Matthias Guckenberger   11 , MD ;   Claus Belka   12 , MD ;   Peter Bartenstein   13 , MD ;   George Hruby   14 , MD ;   Louise Emmett   15 , MD ;   Ali Afshar Omerieh   16 , MD ;   Nina-Sophie Schmidt-Hegemann   17 , MD ;   Lucas Mose   18 , MD ;   Daniel M Aebersold   18 , MD ;   Constantinos Zamboglou   5 , MD ;   Thomas Wiegel   3 , MD ;   Mohamed Shelan   18 , MD

1 European Hospital Georges-Pompidou., Clinical research unit, INSERM Clinical Investigation Center., Paris Cité University, Paris, France

2 Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

3 Department of Radiation Oncology, University of Ulm, Ulm, Germany

4 Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany

5 Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus

6 Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany

7 Division of Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

8 Department of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

9 Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy

10 Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany

11 Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland

12 Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany

13 Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany

14 Department of Radiation Oncology, Royal North Shore Hospital–University of Sydney, Sydney, Australia

15 Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital Sydney, Sydney, Australia

16 Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

17 Department of Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland

18 Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Corresponding Author:

  • Mohamed Shelan, MD
  • Department of Radiation Oncology
  • Inselspital, Bern University Hospital
  • University of Bern
  • Freiburgstrasse 10
  • Bern, 3010
  • Switzerland
  • Phone: 41 41316322632
  • Email: mohamed.shelan@insel.ch